A panel of 10 neuroendocrine tumor (NET) medical experts will gather for an online conversation about COVID-19 and its impact on NET patients. Patients, families, and caregivers are invited to submit questions and panelists will answer as many as possible during the online program. The program, presented by the North American Neuroendocrine Tumor Society (NANETS), is scheduled for Thursday, April 23 from 8:00 to 9:20 pm, Eastern Time.
Registration is now open. Register and submit questions here
The panelists are:
Medical Oncology
Emily Bergsland, MD, University of California San Francisco, School of Medicine
Daniel Halperin, MD, University of Texas, MD Anderson Cancer Center
Heloisa Soares, MD, PhD, Huntsman Cancer Institute, University of Utah Health
Surgery
Alexandra Gangi, MD, Cedars Sinai, Samuel Oschin Comprehensive Cancer Center
James Howe, MD, University of Iowa, Carver College of Medicine
Gastroenterology
David Metz, MD, University of Pennsylvania, Perelman Center for Advanced Medicine
Nuclear Medicine
Lisa Bodei, MD, PhD, Memorial Sloan Kettering Cancer Center
Interventional Radiology
Michael Soulen, MD, Hospital of the University of Pennsylvania
Facilitators
Arvind Dasari, MD, medical oncologist, University of Texas, MD Anderson Cancer Center
Joseph Dillon, MD, endocrinologist, University of Iowa, Carver College of Medicine
NANETS and its panel participants recognize every patient situation is unique, and all decisions should be made in consultation with a patient’s health care providers.
NANETS collaborated with several NET patient organizations to bring this event to the NET community. The Carcinoid Cancer Foundation is proud to be one of the collaborators for the program.
